SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
CHEMOCENTRYX INC
(NQNM:CCXI Last Sale: 54.54 +0)
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQNM: (CCXI : $54.54)
$3,370,172 million Market Cap at Market Close, July 1, 2022
Biomedics SubIndustry up .00% / Health Industry up .00% Today
Research Report Earnings Snapshot - Last 11/05/18
Fact Sheet
Financial Statements
Peer Comparison
Annual Reports


Focus on the chemokine system. Developing drugs for Crohn's disease, diabetic nephropathy, a form of kidney disease, rheumatoid arthritis other disorders. Glaxo Group Limited and Techne Corporation are affilates and shareholders. IPO at $10 February 8, 2012. Raised $45 million, selling 4.5 million shares, 13% of the outstanding. Lead Manager: J.P. Morgan.
Historical Charts    Technical Analysis
No Historical Data available for CCXI

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common CCXI $54.54 $54.54 0 .0 $50.99 $54.83 625,054 $50.99 $54.83 61,792,661
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock #############

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex